NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021
2021 · Journal of the National Comprehensive Cancer Network · 314 citations
https://doi.org/10.6004/jnccn.2021.0002
T
Thomas Prébet
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
343
Papers
8.9K
Citations
48
h-index
135
i10-index
Thomas Prébet is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 48, co-authored 292 publications.
ORCID: 0000-0002-6872-625XPapers by this author
worksEfficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
2023 · The Lancet · 154 citations
https://doi.org/10.1016/s0140-6736(23)00874-7
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
2022 · The Lancet Haematology · 111 citations
https://doi.org/10.1016/s2352-3026(22)00292-7
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial
2022 · Journal of Hematology & Oncology · 31 citations
https://doi.org/10.1186/s13045-022-01361-w
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
2023 · Annals of Hematology · 21 citations
https://doi.org/10.1007/s00277-023-05109-5
Olutasidenib (FT-2102) in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Acute Myeloid Leukemia
2021 · Blood · 11 citations
https://doi.org/10.1182/blood-2021-144905
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat